Category:Francesco G. Salituro of Marlborough MA (US)

From WikiPatents
Jump to navigation Jump to search

Francesco G. Salituro of Marlborough MA (US)

Executive Summary

Francesco G. Salituro of Marlborough MA (US) is an inventor who has filed 18 patents. Their primary areas of innovation include Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton (11 patents), STEROIDS (seco-steroids (7 patents), STEROIDS (seco-steroids (4 patents), and they have worked with companies such as Sage Therapeutics, Inc. (13 patents), SAGE THERAPEUTICS, INC. (5 patents). Their most frequent collaborators include (13 collaborations), (11 collaborations), (11 collaborations).

Patent Filing Activity

Francesco G. Salituro of Marlborough MA (US) Monthly Patent Applications.png

Technology Areas

Francesco G. Salituro of Marlborough MA (US) Top Technology Areas.png

List of Technology Areas

  • C07J43/003 (Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton): 11 patents
  • C07J9/00 (STEROIDS (seco-steroids): 7 patents
  • C07J9/005 (STEROIDS (seco-steroids): 4 patents
  • C07J31/006 (STEROIDS (seco-steroids): 4 patents
  • C07J13/007 (Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 {(for carbonyl groups): 3 patents
  • C07J41/0094 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring): 3 patents
  • C07J17/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide): 3 patents
  • A61P25/20 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 3 patents
  • A61K31/58 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 3 patents
  • A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 3 patents
  • C07J7/002 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms (): 3 patents
  • C07J41/0044 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring): 2 patents
  • C07B2200/05 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation): 2 patents
  • A61P25/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
  • A61P25/24 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
  • C07J7/0085 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms (): 2 patents
  • A61K31/575 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
  • C07J7/007 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms (): 2 patents
  • C07J21/00 (STEROIDS (seco-steroids): 2 patents
  • C07J13/005 (Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 {(for carbonyl groups): 1 patents
  • C07J21/008 (STEROIDS (seco-steroids): 1 patents
  • C07J41/0061 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring): 1 patents
  • C07J63/008 (STEROIDS (seco-steroids): 1 patents
  • A61K31/57 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • A61P1/00 (Drugs for disorders of the alimentary tract or the digestive system): 1 patents
  • A61P19/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P25/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P25/22 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P35/00 (Antineoplastic agents): 1 patents
  • A61P25/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • A61P25/14 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C07J1/0011 (STEROIDS (seco-steroids): 1 patents
  • C07J1/0022 (STEROIDS (seco-steroids): 1 patents
  • C07J3/005 (Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom): 1 patents
  • C07J5/0053 (STEROIDS (seco-steroids): 1 patents
  • C07J7/008 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms (): 1 patents
  • C07J11/00 (STEROIDS (seco-steroids): 1 patents
  • C07J41/0066 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring): 1 patents
  • C07J51/00 (Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups): 1 patents
  • C07J71/001 (Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring (spiro-condensed heterocyclic rings): 1 patents
  • A61P3/00 (Drugs for disorders of the metabolism (of the blood or the extracellular fluid): 1 patents
  • A61P23/00 (Anaesthetics): 1 patents
  • C07J73/003 (Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms): 1 patents

Companies

Francesco G. Salituro of Marlborough MA (US) Top Companies.png

List of Companies

  • Sage Therapeutics, Inc.: 13 patents
  • SAGE THERAPEUTICS, INC.: 5 patents

Collaborators